System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Review Epublish

PubMed: 42739713 DOI: 10.3390/jcm15176708

Dextrose Injections Across Temporomandibular Joint Mobility Disorders: A Scoping Review.

J Clin Med 15(17)

Authors: Julia Kasprzycka, Maciej Chęciński, Justyna Wilk, Wojciech Macek, Maja Kosińska, Amelia Hoppe, Oliwia Jagiełło, Karolina Grzybowska-Kowalczyk, Tomasz Horodniczy, Zuzanna Baniak, Izabella Chyży, Kamila Chęcińska, Maciej Sikora

Affiliations

  • Miodowa Clinic, Głowaccy Medical and Dental Practice Professional Partnership, Kiekrz, Miodowa 2, 62-090 Rokietnica, Poland.
  • National Medical Institute of the Ministry of the Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland.
  • Department of Maxillofacial Surgery, Hospital of the Ministry of the Interior and Administration, Wojska Polskiego 51, 25-375 Kielce, Poland.
  • Ortosfera Orthodontic Practice, Władysława Reymonta 2, 33-300 Nowy Sącz, Poland.
  • Department of Oral Surgery, Preventive Medicine Center, Komorowskiego 12, 30-106 Cracow, Poland.
  • Gabinety Lekarskie Dent-im M.B. Pawelczyk Spółka Jawna, Różana 13/1, 61-577 Poznań, Poland.
  • Uśmiech Family Dental Clinic, Nastrojowa 26, 91-496 Łódź, Poland.
  • Ortho.pl Dental Office, Buforowa 34, 52-131 Wrocław, Poland.
  • Stomatologia Centrum, Moniuszki 3/7, 32-020 Wieliczka, Poland.
  • Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.

Abstract

Background/Objectives: Temporomandibular joint (TMJ) mobility disorders encompass opposing clinical problems, ranging from hypermobility, subluxation, and recurrent dislocation to restricted mandibular mobility caused by disc displacement without reduction (DDwoR). Dextrose-based injections have been investigated in both settings, although their therapeutic objectives may differ. This scoping review mapped the clinical indications, injection protocols, outcomes, safety findings, and evidence gaps. Methods: PubMed/MEDLINE, Europe PMC, and BASE were searched from inception through 14 June 2026. Study selection and data charting were conducted independently by two reviewers, and primary studies underwent design-specific JBI appraisal. Results: Eighteen reports were included: 14 reports describing 13 primary clinical studies (two reports were companion publications from the same randomized pilot cohort) and four systematic reviews used for evidence mapping. Among the primary studies, twelve addressed excessive TMJ mobility, and one evaluated DDwoR with limited mouth opening. In hypermobility and recurrent dislocation, within-group reductions in pain, excessive mouth opening, and recurrence were commonly reported, but superiority over placebo or active comparators was inconsistent. In DDwoR, 5% dextrose was associated with improvements in pain, mouth opening, and chewing function, although the evidence was limited by the small sample. No serious adverse events were reported. Conclusions: Substantial heterogeneity precluded quantitative synthesis and prevented identification of an optimal protocol. Indication-specific, adequately powered randomized trials with standardized outcomes and longer follow-up are required.

MeSH

Injections, Pain, Prolotherapy, Joint Dislocations, Mouth